Monday, December 5, 2016

MabVax Extends Clinical Trials

San Diego-based MabVax Therapeutics, which develops oncology drugs, said it is expanding a Phase I clinical trial for patients with pancreatic cancer. The company said it has started including patients at HonorHealth Research Insitute, in Scottsdale, Arizona in its studies, joining Memorial Sloan Kettering Cancer Center site in New York, and the Sarah Cannon Research Institute sites in Nashville, Tennessee and, Sarasota, Florida.

---